Wilder-Oregano-Öl


Wirkung

Einleitung

Indikationen

Angesichts der bisher beobachteten Wirkungen und Mechanismen von Oregano-Öl ließe sich durchaus spekulieren, dass sich die therapeutische Bandbreite von Wilder- Oregano-Öl unter anderem auch in einer hemmenden Wirkung auf Provokationen der Leber durch bakterielles LPS aus dem menschlichen Darm über das Pfortadersystem äußern könnte. Derartige Provokationen über den menschlichen Darm sind Teil des Erklärungsmodells für das Persistieren niedriggradiger Entzündungssyndrome als kausaler Mechanismus für viele Pathologien wie das metabolische Syndrom, Herz-Kreislauf-Erkrankungen, Typ-2-Diabetes und verschiedene altersbedingte (neuro-) degenerative Erkrankungen. Angesichts der Beobachtungen, die auf eine Verbesserung der Gesundheit des Dünndarms und seiner Zotten hindeuten, sowie die Fähigkeit, Opportunisten wie Candida und andere Darmpathogene zu dezimieren, lässt sich nicht leugnen, dass Wilder-Oregano-Öl potenziell über einen hohen klinischen Wert verfügt. Darüber hinaus können die spezifischen entzündungshemmenden und PPAR-aktivierenden Eigenschaften dazu beitragen, Insulinresistenz zu verringern und den Glucose- und Fettstoffwechsel zu normalisieren. Weitere In-vivo-Studien und klinische Forschung zur Anwendung von Oregano-Öl beim Menschen sind notwendig, um seine medizinische Bedeutung weitergehend zu bestimmen.

Nebenwirkungen

Oregano- und Oregano-Öl gelten in Amerika und Europa als sicherer Lebensmittelzusatzstoff. Weiterhin sind von Oregano-Öl keine unerwünschten Nebenwirkungen bekannt.

Synergie

Laurinsäure aus Kokosöl zerfällt im Körper zu Monolaurin, das in vitro eine dem wilden Oreganoöl ähnliche Wirkung auf Mikroorganismen zeigt und auch in vivo eine synergistische Wirkung gegen Staphylococcus aureus aufweist. In-vitro-Forschung zeigt auch eine antibakterielle Synergie der Phenole aus Oregano und Cranberry gegen Helicobacter pylori.

Referenzen

  1. Pharmakognosie/Ernst Steinegger; Rudolf Hänsel; Springer 1992.
  2. Groot handboek geneeskrachtige planten/Dr Geert Verhelst; BVBA Mannavita; 3e druk, April 2003
  3. Dorman HJ, Deans SG. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J Appl Microbiol 20 Feb; 88 (2):308-16. PMID: 10736000
  4. Baser KH. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des. 2008;14(29):3106-19. PMID: 19075694
  5. Parnas M, Peters M Dadon D, et al. Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. Cell Calcium. 2009 March ; 45(3): 300–309. doi:10.1016/j.ceca.2008.11.009.
  6. Peixoto-Neves D, Silva-Alves KS, Gomes MD, et al. Vasorelaxant effects of the monoterpenic phenol isomers, carvacrol and thymol, on rat isolated aorta. Fundam Clin Pharmacol. 2010 Jun;24(3):341-50. Epub 2009 Aug 13.
  7. Yoshino K, Higashi N. Antioxidant and Antiinflammatory Activities of Oregeno Extract. Journal of health Science, 2006; 52(2):169-173
  8. Hotta M, Nakata R, Katsukawa M, et al. Carvacrol, a component of thyme oil, activates PPARalpha and gamma and suppresses COX-2 expression. J Lipid Res. 2010 Jan;51(1):132-9. PMID: 19578162
  9. Aristatile B, Al-Numair KS, Veeramani C, Pugalendi KV. Antihyperlipidemic effect of carvacrol on D-galactosamine-induced hepatotoxic rats. Basic Clin Physiol Pharmacol. 2009;20(1):15-27. PMID: 19601392.
  10. Josephs MD, Bahjat FR, Fukuzuka K, et al. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand. Am J Physiol Regul Integr Comp Physiol. 2000 May;278(5):R1196-201. PMID: 10801287
  11. Nishioka H , Kishioka T , Iida C , et al. Activation of mitogen activated protein kinase (MAPK) during D-galactosamine intoxication in the rat liver. Bioorg. Med. Chem. Lett. 2006 Jun; 16(11 ):3019-22. PMID: 16530410
  12. Kwon Y, Vattem D, Shetty K. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac J Clin Nutr. 2006;15:107-118.
  13. Talpur N, Echard B, Ingram C, Bagchi D, Preuss H. Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats: a pilot study. Diabetes Obes Metab. 2005;7:193-199.
  14. Aydin Y, Kutlay O, Ari S, Duman S, Uzuner K, Aydin S. Hypotensive effects of carvacrol on the blood pressure of normotensive rats. Planta Med. 2007;73:1365-1371.
  15. Slamenova D, Horvathova E, Marsalkova L, Wsolova L. Carvacrol given to rats in drinking water reduces the level of DNA lesions induced in freshly isolated hepatocytes and testicular cells by H(2)O(2). Neoplasma. 2008;55(5):394-9. PMID: 18665749
  16. Nostro A, Marino A, Blanco AR, et al. In vitro activity of carvacrol against staphylococcal preformed biofilm by liquid and vapour contact .Journal of Medical Microbiology (2009), 58, 791–797. PMID 19429756
  17. Ben Arfa A, Combes S, Preziosi-Belloy L, Gontard N. & Chalier, P. (2006). Antimicrobial activity of carvacrol related to its chemical structure. Lett Appl Microbiol 43, 149–154. PMID: 16869897
  18. Chami, N., Bennis, S., Chami, F., Aboussekhra, A. & Remmal, A. (2005). Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol Immunol 20, 106–111. PMID: 15720571
  19. Dorman HJ, Deans SG. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J Appl Microbiol 20 Feb; 88 (2):308-16. PMID: 10736000
  20. Jeong, E. Y., Lim, J. H., Kim, H. G. & Lee, H. S. (2008). Acaricidal activity of Thymus vulgaris oil and its main components against Tyrophagus putrescentiae, a stored food mite. J Food Prot 71, 351–355. PMID: 18326186
  21. Kordali, S., Cakir, A., Ozer, H., Cakmakci, R., Kesdek, M. & Mete, E. (2008). Antifungal, phytotoxic and insecticidal properties of essential oil isolated from Turkish Origanum acutidens and its three components, carvacrol, thymol and p-cymene. Bioresour Technol 99, 8788–8795. PMID: 18513954
  22. Ultee, A., Gorris, L. G. & Smid, E. J. (1998). Bactericidal activity of carvacrol towards the food-borne pathogen Bacillus cereus. J Appl Microbiol 85, 211–218. PMID: 9750293
  23. Ultee, A., Kets, E. P. W. & Smid, J. (1999). Mechanisms of action of carvacrol on the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 65, 4606–4610. PMID: 10508096
  24. Ultee, A., Bennik, M. H. & Moezelaar, R. (2002). The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 68, 1561–1568. PMID: 11916669
  25. Lambert, R. J. W., Skandamis, P. N., Coote, P. J. & Nychas, G. J. E. (2001). A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J Appl Microbiol 91, 453–462. PMID: 11556910
  26. Gill, A. O. & Holley, R. A. (2006). Inhibition of membrane bound ATPases of Escherichia coli and Listeria monocytogenes by plant oil aromatics. Int J Food Microbiol 111, 170–174. PMID: 16828188
  27. Liolios CC, Graikou K, Skaltsa E, Chinou I. Dittany of Crete: a botanical and ethnopharmacological review. J Ethnopharmacol. 2010 Sep 15;131(2):229-41. PMID: 20633631
  28. Burt SA, van der Zee R, Koets AP, et al. Carvacrol Induces Heat Shock Protein 60 and Inhibits Synthesis of Flagellin in Escherichia coli O157:H7. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, July 2007; 73(14): 4484–90. PMID: 17526792
  29. Burt SA, Reinders RD. Antibacterial activity of selected plant essential oils against Escherichia coli O157:HLett Appl Microbiol. 2003;36(3):162-7. PMID: 12581376
  30. Preuss HG, Echard B, Dadgar A,et al. Effects of Essential Oils and Monolaurin on Staphylococcus aureus: In Vitro and In Vivo Studies. Toxicol Mech Methods. 2005;15(4):279-85. PMID: 20021093
  31. Nostro A, Blanco AR, Cannatelli MA, et al. Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol. FEMS Microbiol Lett. 2004 Jan 30;230(2):191-5. PMID: 14757239
  32. Manohar V, Ingram C, Gray J, et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem. 2001 Dec;228(1-2):111-7. PMID: 11855736
  33. Tampieri MP, Galuppi R, Macchioni F, et al. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia. 2005 Apr;159(3):339-45. PMID: 15883716
  34. Salgueiro LR, Cavaleiro C, Pinto E, et al. Chemical composition and antifungal activity of the essential oil of Origanum virens on Candida species. Planta Med. 2003 Sep;69(9):871-4. PMID: 14598221
  35. Giordani R, Regli P, Kaloustian J, et al. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Phytother Res. 2004 Dec;18(12):990-5. PMID: 15742351
  36. Rosato A, Vitali C, Gallo D, Balenzano L, Mallamaci R. The inhibition of Candida species by selected essential oils and their synergism with amphotericin B. Phytomedicine. 2008 Aug;15(8):635-8. PMID: 18579358
  37. Kacem R, Meraihi Z. Effects of essential oil extracted from Nigella sativa L. seeds and its main components on human neutrophil elastase activity. Yakugaku Zasshi 2006; 126: 301-5. BRON: Baser KH. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des. 2008;14(29):3106-19. PMID: 19075694
  38. Jukic M, Politeo O, Maksimovic M, Milos M. In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone. Phytother Res. 2007 Mar;21(3):259-61. PMID: 17186491
  39. Melo FH, Venâncio ET, de Sousa DP, et al. Anxiolytic-like effect of Carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission. Fundam Clin Pharmacol. 2010 Aug;24(4):437-43. PMID: 19909350
  40. Melo FH, Moura BA, de Sousa DP, et al. Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: involvement of dopaminergic system. Fundam Clin Pharmacol. 2010 Jun 30. PMID: 20608992
  41. Michiels J, Missotten J, Van Hoorick A, et al. Effects of dose and formulation of carvacrol and thymol on bacteria and some functional traits of the gut in piglets after weaning. Arch Anim Nutr. 2010 Apr;64(2):136-54. PMID: 20481352
  42. Force M, Sparks WS, Ronzio RA, et al. Inhibition of enteric parasites by emulsified oil of oregano in vivo. Phytother Res. 2000 May;14(3):213-4. PMID: 10815019
  43. Machado M, Sousa Mdo C, Salgueiro L, Cavaleiro C. Effects of essential oils on the growth of Giardia lamblia trophozoites. Nat Prod Commun. 2010 Jan;5(1):137-41. PMID: 20184039
  44. Machado M, Dinis AM, Salgueiro L, et al. Anti-Giardia activity of phenolic-rich essential oils: effects of Thymbra capitata, Origanum virens, Thymus zygis subsp. sylvestris, and Lippia graveolens on trophozoites growth, viability, adherence, and ultrastructure. Parasitol Res. 2010 Apr;106(5):1205-15. PMID: 20217133
  45. Ponce-Macotela M, Rufino-González Y, González-Maciel A, et al. Oregano (Lippia spp.) kills Giardia intestinalis trophozoites in vitro: antigiardiasic activity and ultrastructural damage. Parasitol Res. 2006 May;98(6):557-60. PMID: 16425064
  46. Akgul A, Kivanc M. Inhibitory effects of selected Turkish spices and oregano components on some foodborne fungi. Int J Food Microbiol 1988;6:263-268. PMID 2978951
  47. Bergsson G, Arnfinnsson J, Steingrimsson O, Thormar H. In Vitro Killing of Candida albicans by Fatty Acids and Monoglycerides. Antimicrobial Agents And Chemotherapy. Nov 2001; 45(11):3209-12. PMID: 11600381
  48. Lin YT, Kwon YI, Labbe RG, Shetty K. Inhibition of Helicobacter pylori and Associated Urease by Oregano and Cranberry Phytochemical synergies. Applied and Environmental Microbiology. 2005 Dec;71(12):8558-64. PMID 16332847
  49. Zwolinska-Wcislo, Brzozowski T, Mach T, et al, Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol. 2006 Nov;57 Suppl 9:35-49. PMID: 17242486
  50. Center for Food Safety and Applied Nutrition (2006). EAFUS: a Food Additive Database. Washington, DC: US Food and Drug Administration, Center for Food Safety and Applied Nutrition.
  51. Commission of the European Communities (1999). Commission Decision of 23 February 1999 Adopting a Register of Flavouring Substances Used in or on Foodstuffs Drawn Up in Application of Regulation (EC) No. 2232–96 of the European Parliament and of the Council of 28 October 1996 (Notified under Number C(1999) 399) (Text with EEA Relevance) (1999/217/EC). Official Journal of the European Communities L084, pp. 1–137. Brussels, Belgium: Commission of the European Communities.
  52. Singletary K. Oregano: Overview of the Literature on Health Benefits. Nutrition today. May/June 2010; 45(3):129-38. doi: 10.1097/NT.0b013e3181dec789
  53. Stiles JC, Sparks W, Ronzio RA. The inhibition of Candida albicans by Oregano. J Applied Nutr 1995;47:96-102. BRON: Citaat uit Timothy C. Birdsall, "Gastrointestinal Candidiasis: Fact or Fiction?". Alternative Medicine Review. Volume 2, Number 5 1997
  54. Erica White, Dip.ION; Caroline Sherlock, B.A.(ss), Lic.ION "Nutritional Therapy for Candidiasis in Cases of Chronic Fatigue Syndrome". Journal of Orthomolecular Medicine. Vol. 20, No. 3, 2005.

Uw profiel

Ja, schrijf mij in voor de tweewekelijkse nieuwsbrief en blijf op de hoogte van de nieuwste inzichten over gezondheid, events en webinars.
Ja, ik ga akkoord met de Privacy Statement van Natura Foundation

Cookies

Wenn Sie Ihren Besuch dieser Website fortsetzen und Inhalte durch Anklicken öffnen, stimmen Sie damit der Verwendung von Cookies zu. Mit Cookies sammeln wir Daten zu den Aktivitäten von Besuchern auf unserer Website. Mit diesen Daten erhöhen wir den Benutzungskomfort unserer Website und zeigen Ihnen diejenigen Informationen an, die Sie am meisten interessieren. Wenn Sie keine Cookies akzeptieren, können Sie keine Videos ansehen oder Inhalte auf sozialen Medien teilen.  Mehr Informationen.

Eigene Einstellungen für Cookies festlegen